Ligand Pharmaceuticals — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Viking Therapeuticsvikingtherapeutics.com inNASDAQ: VKTXJun 2017

Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders.

BiotechHealthtechLongevitySan Diego, US

Brian Lian(President, CEO & Director (Founder))inMichael Morneau(Chief Financial Officer)Dr. Lian(President & Chief Executive Officer, Director)Stephen W. Webster(Director)Matthew W. Foehr(Director)

BoardJ. Matthew Singleton(Director)

Co-investorsAvoro Capital Advisors

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.